BioLife Solutions reported third-quarter 2025 results, with revenue of US$28.07 million and net income of US$621,000, also updating its full-year guidance upward after completing the sale of its evo ...

TORONTO, ONTARIO, Nov. 09, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire – BioLife Sciences Inc. (OTCPK:BLFE) announces it has initiated the process of up-listing to the Over the Counter Quotation Bureau ...

CEO Roderick de Greef highlighted a strong start to 2025, with total revenue growing 30% year-over-year and cell processing revenue increasing by 33%. He emphasized the company’s focus on strategic ...

BOTHELL, Wash., Aug. 13, 2013 /PRNewswire/ -- BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and ...

HENDERSON, NV, Aug 10, 2022 – BioLife Sciences Inc. (BioLife), a commercialization accelerator, licensor and developer of technologies, has reportedly provided investors with a significant company ...

CEO Roderick de Greef highlighted strong quarterly performance, stating that "cell processing revenue increased 33% year-over-year, driving a 31% increase in total revenue for the quarter." He ...

WORCESTER, Mass.--(BUSINESS WIRE)--BioLife Plasma Services, part of the global biopharmaceutical company Takeda, today announced the opening of a new plasma center in Worcester, MA, to help meet the ...

CEO Roderick de Greef reported, "We delivered another strong quarter as our team continues to execute and build on the momentum established over the last several quarters." Cell processing revenue ...

TUKWILA, Wash.--(BUSINESS WIRE)--BioLife Plasma Services, part of the global biopharmaceutical company Takeda Pharmaceutical Company Limited, today announced the opening of an all-electric plasma ...